 |
bendamustine hydrochloride with betadex sulfobutyl ether sodium |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2013-09-10 00:00:00 |
| Sponsor | Supratek Pharma, Inc.;6100 Royalmount Avenue, H4P 2R2;Quebec |
